PFE Pfizer Inc: Market Capitalization to Book Value Ratio

The market-to-book ratio demonstrates Pfizer Inc. (PFE) shifting its strategy toward high-margin oncology through M&A transactions. This metric currently stands at 1.98 as the market digests the decline in COVID-related sales and awaits the impact of the Seagen integration. The asset's fundamental stability is underscored by colossal investments in a complex ultra-cold chain logistics system for global drug delivery.

Pfizer Inc. (PFE) - Market Capitalization to Book Value Ratio from 07/04/2022 to 10/27/2026

PFE (Pfizer Inc): analytical breakdowns and indicator data

- price and consensus price forecast:

Price Chart Pfizer Inc.|PFE - Forecast Levels Chart

- market capitalization data:

Market Capitalization Pfizer Corporation|PFE - Value Adjusted for Debt and Cash

- book capitalization data:

Book Value per Share Pfizer|PFE - Book Capitalization|Market Value to Book Value Ratio pfizer.com|PFE - Aggregate Asset Value

- debt and liquidity data:

Debt to Equity Pfizer Inc.|PFE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Pfizer Corporation|PFE - Company Aggregate Debts|Debt to Book Value Pfizer Corporation

Basic company analysis:PFE (Pfizer Inc.)

To stress-test positions, an investor must compare the current market value of shares with the company's actual net asset value. By relying on the market valuation of book capitalization, one can determine whether the diversified vaccine and oncology portfolio of Pfizer Inc. (PFE) justifies the exchange premium, which allows for the assessment of the business's overvaluation relative to its tangible fundamentals.

Competitor analysis